Page 3«..2345..1020..»

Midlands Woman Goes From Clinic Volunteer to Breast Cancer Survivor – WLTX.com

Posted: August 20, 2017 at 4:46 pm

A breast cancer survivor goes from patient to volunteer.

Darci Strickland, wltx 9:55 PM. EDT August 19, 2017

Cathy McDonald rings the bell after completing her last day of chemotherapy. (Photo: WLTX)

Kershaw County, SC (WLTX) — Cathy McDonald has volunteered at the Kershaw County Community Medical Clinic, which helps the uninsured and underinsured in the community.

The clinic has a memorial garden filled with stones, each inscribed with the name of a volunteer who has passed away.

“I thank God because my name could have been down here, but it’s not,” said McDonald.

McDonald went from being a patient advocate, to a volunteer, to a breast cancer survivor, after recently ringing the bell and completing her last day of chemotherapy.

During a self-breast check, McDonald found a lump in her breast. Her doctors said it was early detection that saved her life. Her sister died two years ago from breast cancer.

“When I hear the word cancer now, I don’t get so upset, you have a fighting chance,” said McDonald.

2017 WLTX-TV

More here:
Midlands Woman Goes From Clinic Volunteer to Breast Cancer Survivor – WLTX.com

Posted in Breast Cancer | Comments Off on Midlands Woman Goes From Clinic Volunteer to Breast Cancer Survivor – WLTX.com

Chicago making progress in closing racial gap in breast cancer deaths – Chicago Sun-Times

Posted: at 4:46 pm

Chicago is making remarkable progress in a longstanding battle to improve public healthby closing the mortality gap between black and white women diagnosed with breast cancer.

According to a new study published by Cancer Cause & Control, an international journal of studies of cancer in human populations, Chicago made the most progress among nine major cities with the nations largest black populations in reducing racial disparities in breast cancer mortality.

Over the four year period ending in 2013, the mortality rate from breast cancer among black women in Chicago dropped by 13.9 percent. The gap between black and white women narrowed by more than 20 percent during the same period.

Even with the improvement, African-American women in Chicago have a breast cancer mortality rate thats 50 percent higher than non-Hispanic white women with similar rates of diagnosis.

The persistent gap has been blamed on structural inequities that lead poor women, many of them minorities, to receive lower-quality mammograms or none at all. The later the diagnosis, the lower the chance of survival.

To show progress in this area is dramatic and remarkable. Were very pleased, Chicago Health Commissioner Dr. Julie Morita said Wednesday.

However, were never satisfied when theres a disparity that remains. So well continue our efforts to close that [gap] and also to continue the progress were making with breast cancer among all womannot just African-Americans.

To chip away at the racial gap, the Health Department is investing $700,000 in community partners charged with bolstering comprehensive breast health services for African-American women and others who have faced historical obstacles to access.

Those partners include: Cook County Health and Hospital System; Rush University Medical Center; Miles Square Health Center; Metropolitan Chicago Breast Cancer Task Force; Sinai Health System and Centro Comunitario Juan Diego.

Those organizations are increasing breast cancer screenings and ensuring that high-risk, medically underserved women receive high-quality follow-up treatment.

Early diagnosis helps improve the outcome. So making sure mammography services are available so people can be screened, raising awareness so people know they should get screened are really important. Making sure that individuals are connected to services that are convenient and high-quality is also really important, Morita said.

We have to make sure that those individuals who are diagnosed actually get connected to appropriate care and treatment as well. So were taking it a step further.

Dr. Patricia Robinson, a breast oncologist at Loyola University Medical Center, said improving care to under-served populations, providing higher-quality machines in smaller hospitals and educating patients about mammogram screening adherence and personal risk relative to family history can only go so far.

If you look beyond the city of Chicago in why there is a disparity in outcomes between African-Americans and other patient populations, it is because our tumor biology may be a little different, Robinson said.

African-American women are more likely to present with triple-negative breast cancers. Theyre more likely to present with more aggressive, higher-grade lymph node- positive breast cancers. And prognostically, those women are more likely to go on to develop metastatic disease.

Four years ago, Chicago expanded a program that provides free mammograms to uninsured women by nearly 1,500 patients despite a state funding cutoff triggered by alleged mismanagement.

The decision to absorb the $300,000 state cut and bankroll a $200,000 expansion at nearly shuttered Roseland Community Hospital was aimed at saving lives through early diagnosis.

At the time, Roseland and the surrounding communities of Beverly, Washington Heights and Auburn Gresham had Chicagos four highest rates of premature death from breast cancer.

This is . . . an attempt to address the disparities that exist in health care services, Mayor Rahm Emanuel told a news conference on that day at Roseland Community Hospital.

Its all about access. It is one of the few cancers in which, if you diagnose it early enough, you can actually deal with it.

Then-Health Commissioner Dr. Bechara Choucair said then that Roseland Community had a top-notch mammography machine, even though the financially strapped hospital came close to closing its doors.

Women in these neighborhoods who have breast cancer are dying at a younger age than the rest of the city. And we know how we can resolve this by making sure that more women are getting screened, Choucair said then.

Earlier that same year, the state cut off funding for the citys mammography program amid allegations that the Health Department was having unqualified people diagnose women with abnormal mammograms and taking too long to refer them for follow-up exams.

See the original post here:
Chicago making progress in closing racial gap in breast cancer deaths – Chicago Sun-Times

Posted in Breast Cancer | Comments Off on Chicago making progress in closing racial gap in breast cancer deaths – Chicago Sun-Times

Mother-daughter team kayaks 300 miles to raise awareness for breast cancer – FOX 29 News Philadelphia

Posted: at 4:46 pm

BURLINGTON CITY – A mother-daughter team is about to set off on an incredible journey. The two are planning to kayak 300 miles, and all for a good cause. The mother is a breast cancer survivor. Now, she and her daughter are hoping to make a difference for people going through the same battle.

The mother-daughter team arrived along the Delaware River in Burlington City on Saturday night after another 15 miles of kayaking, all part of a 300-mile journey to raise awareness for and support breast cancer research.

59-year-old Carolyn Choate and her daughter Sydney Turnbull have paddled close to 140 miles in the last week, almost halfway to their end goal of Baltimore Harbor next weekend.

Carolyn was diagnosed and successfully treated for breast cancer 14 years ago. She credits the work of doctors at the University of Maryland School of Medicine for her lifesaving treatment.

With her expansive kayaking journey, Carolyn wants to tribute Dr. Brodie, who created the life-saving drug the aromataseinhibitor for those diagnosed with breast cancer. She also wants to show that after doctors gave her three years to live, she went on to live 14 more. Its a message of hope, she says.

Having her daughter there, she says, also acts as a reminder that the next generation needs to stay committed to the importance of cancer research.

See more here:
Mother-daughter team kayaks 300 miles to raise awareness for breast cancer – FOX 29 News Philadelphia

Posted in Breast Cancer | Comments Off on Mother-daughter team kayaks 300 miles to raise awareness for breast cancer – FOX 29 News Philadelphia

Olivia Newton-John Says She’s "Feeling Great" 3 Months After Revealing Breast Cancer Relapse – E! Online

Posted: August 19, 2017 at 2:45 pm

Olivia Newton-John looks and feels great about three months after she revealed she had suffered a relapse of breast cancer.

The 68-year-oldGreasealumand singer gave her health updatethis week in a Facebook video message to promote the new “We Go Together” new fundraising campaign for the Olivia Newton-John Cancer Wellness &Research Centrein Melbourne.

“Hello everyone, Olivia Newton John here,” she says in the clip. “Personally, I’d like express my gratitude to all of you who sent such kind and loving messages of support over the past few months. Your prayers and well-wishes have truly helped me and continued to lift my spirits. I’m feeling great and so look forward to seeing you soon.”

Newton-Johnhad announced in late Maythat she was diagnosed withbreast cancer that had metastasized to the sacrum, a bone in the lower back, would undergoa short course of photon radiation therapy and natural wellness therapies. She said she is”reluctantly” postponing the remainder of her North America tour dates. She is set to resume touring on Thursday, starting with a show in Indiana.

“During this healing time, recovering from my breast cancer relapse, I’ve had time to reflect on how proud I am of the center and the important contribution it makes to the lives of communities it serves,” she said in her video message.

“The success of our supportive care programs, plus the groundbreaking and exciting cancer research programs makes us set the bar even higher this year,” she continued. “We need to raise $1 million for the center, so it can continue to grow our critical research, pioneer trials and deliver holistic care to all who are in need. So I’m delighted to launch our new, national campaign, ‘We Go Together.'”

The actress was first diagnosed with breast cancer in 1992 on the same weekend her father died of cancer. She underwent chemotherapy and had a partial mastectomy and breast reconstruction.

In 2008, she built theOlivia Newton-John Cancer and Wellness Centrein Melbourne, Australia.

Read more here:
Olivia Newton-John Says She’s "Feeling Great" 3 Months After Revealing Breast Cancer Relapse – E! Online

Posted in Breast Cancer | Comments Off on Olivia Newton-John Says She’s "Feeling Great" 3 Months After Revealing Breast Cancer Relapse – E! Online

MedStar Health Cancer Network offers less instrusive lumpectomy procedure – Baltimore Sun

Posted: at 2:45 pm

Before having surgery to remove a lump, breast cancer patients must undergo a procedure that typically involves inserting wires into the breast to mark the location of the lump. The process can be painful and make for a long day at the hospital.

Dr. Maen Farha, medical director of the Union Memorial Hospital and Good Samaritan Hospital breast centers, has begun using less intrusive electromagnetic wave technology to locate and remove breast lumps not detectable by touch. He uses a device that provides real-time guidance to insert a reflector directly into the breast lump, according to MedStar Health Cancer Network.

The technology requires placing a 3-millimeter transmitter in a breast lump up to 30 days before surgery. In the operating room, the transmitter is detected by an electromagnetic wave, allowing the surgeon to pinpoint the lump. The transmitter is then removed along with the cancerous tissue.

It means we take less tissue, meaning its less traumatic for breast cancer patients, Farha said. Breast tumors are relatively small, he said, and not being able to easily locate them can result in additional tissue loss.

This is more precise, he said.

The procedure takes about 10 to 15 minutes, Farha said.

Breast cancer is the second-most-common cancer in women, after skin cancer, and chances of getting it increase with age, according to the U.S. Centers for Disease Control and Prevention.

For the past 30 years, the common procedure has been to use needle wire localization, which involves sticking wires into the breast that will protrude through the skin. The process must be done on the day of the surgery.

It makes the day very long, Farha said of the wire procedure. It can also be painful and require a lot of time in an operating room, he said.

Farha is the first and only physician in the state to offer breast cancer patients the new technology, according to the MedStar Health Cancer Network, which comprises four hospitals including Union Memorial and Good Samaritan.

The device, developed by Cianna Medical Inc., went on the market in 2015 and has been approved by the U.S. Food and Drug Administration. Although Ciannas website says its product has been used at over 150 medical facilities and in more than 15,000 procedures through July, not all hospitals are embracing the technology.

Dr. David Euhus, director of the Johns Hopkins Breast Center, said his team evaluated the technology more than a year ago but decided not to use it.

I dont think its the final answer. Someday there will something smaller with a better signal, he said.

At his previous position at the University of Texas Southwestern Medical Center in Dallas, Euhus said, the department used radioactive seeds, which could be inserted two days before surgery and provide a high level of accuracy. But physicians have to account for all the seeds, which provide a dose of radiation to the breast tissue, once they are inserted into a patient.

The electromagnetic wave devices are beneficial, he said, because they dont have to be inserted into a patient on the same day as surgery, making for less time in the operating room.

Its a great step in the right direction, but the final product is going to be small and have a strong signal, Euhus said.

Dr. Farha is more than satisfied with whats currently available.

The convenience factor alone is an advancement that we are pleased to be able to offer, he said in a written statement. More important is [that] the level of precision afforded by this technology gives us an increased probability of removing all the cancer.”

jkanderson@baltsun.com

twitter.com/janders5

Link:
MedStar Health Cancer Network offers less instrusive lumpectomy procedure – Baltimore Sun

Posted in Breast Cancer | Comments Off on MedStar Health Cancer Network offers less instrusive lumpectomy procedure – Baltimore Sun

When Will We Have a Cure for All Forms of Cancer? – Futurism

Posted: at 2:43 pm

Will We Ever Cure Cancer?

Cancer is, without a doubt, one of the most dreaded diagnoses a person can receive in their lifetime. While there are many forms of cancer and their respective prognosis depend on a multitude of factors such as the patient, the cancers stage, and available treatments for the millions of people who will be diagnosed this year, the word cancer is still a frightening one to hear.

The American Cancer Society projected that 1,688,780 new cancercases will be diagnosed in 2017. People of all ages can beamong those diagnosed with one of over 100 different types of cancer.But when we talk about cancer especially when we discuss treatments or cures its important to point out that cancer is not just one disease. Therefore,the likelihood that a single treatment could ever cure all forms of cancer is extremely unlikely.

To frame the search for a cancer cure as being the quest for a single drug or procedure isapproaching the task from within the wrong framework. Rather than developing a single cancer cure-all, many doctors are advocating that we focus instead on developing treatments that are disease-specific and even patient-specific. This strategy is necessary because cancer can arise in different body systems, often several at the same time, and in different people withtheir own unique physiology.

Will such treatments ever exist? When it came to making predictions about when if ever well have a cure for all forms of cancer,Futurism readers were pretty optimistic:25 percent think well get there by the 2030s, 18 percent by the 2040s, and 16 percent think were right on the cusp predicting a cure as soon as the next decade. About 10 percent of readers predicted that wellnevercure cancer.

Brd Pedersen, a reader from Norway, commented I do actually think that it will be possible in the 2020s But due to paperwork, testing en [sic] other legalities it will not be available as legal treatment until mid 2030s. While Pedersen was commenting on the situation where he lives in Norway, approval for new drug treatments is an arduous process around the world. In the U.S., regulation is especially tight and can pose challenges for researchers, medical professionals, and patients alike.

While developing many different andeven personalized treatments may seem like a lofty task, its actually something we have done and are doing. CRISPR has allowed researchers to edit a mouses genome such that their immune cells aregenetically engineered to kill cancer cells.The clinical trials that have been completed thus far indicate it may be a good treatment option for patients with a form of cancer called multiple myeloma, a form of cancer that affects blood plasma cells.

Another mouse study thatthe University of Pittsburgh School of Medicine published earlier this year used genetic engineering to target cancer fusion cells something that had never been done before.It is really exciting because it lays the groundwork for what could become a totally new approach to treating cancer, said the studyslead author Jian-Hua Luo, director at Pitts School of Medicines High Throughput Genome Center, in a press release.These fusion genes two genes that fuse together and produce cancer-promoting proteins may play an instrumental role in many types of cancer.

While this research is promising, many cancer experts are still cautious about the future of the field. Monica Bertagnolli, chair of the Alliance for Clinical Trials in Oncology, toldScientific Americanlast year that even if new treatments are developed and pass through the required regulatory hurdles, it still doesnt mean theyll work for every patient.

Unfortunately, we see some patients dont respond to these wonderfully new therapies and some patients that do respond initially eventually develop resistance to those therapies and so the tumor returns, Bertagnolli said in the interview. Obviously thats in the way of curing cancer because we want a treatment that a patient will never develop resistance to.

Other experts who have devoted their careers to cancer research like Barrie Bode, biology chair at Northern Illinois University acknowledge that there are many possibilities in research to be excited about, but havent become so caught up in the excitement that they lose sight of the reality. When asked if he thinks there will be a cure for cancer in our lifetimes, Bode said no, but added that Sometypesof cancer might be cured thats happened already. But newpharmaceutical cures are rare. Over the next century, Id say the chance is very remote that we will find a single cure for cancer.

Bodes commentary echoes that of many others, butthat isnt to say hesentirely without faith that well continue to make steady progress both in our understanding of cancer and developing more effective treatments. The search for a cure may not be as vital in the years to come as the commitment to developing treatment that can increase a patients quality of life, if not their life expectancy, too. Bode says treatments to come will beinformed by the science and technologies that are available so that cancer can be managed much like other diseases, such as heart disease and diabetes.

If groundbreaking research and clinical trials are to continue,it will need funding.The Cancer Moonshot initiative,which was put into place under former President Obama and has former Vice President Joe Biden at the helm, was allotted$1.8 billion by Congress in December of2016, to be used for the next seven years.Many goals of the programare focused onthe outcome for cancer patients that is the closest we have to a cure: remission. While cancer that has gone into remission can come back,over the last few decades research has allowed patients with many forms of cancer to live long by extending their periods of remission through treatment.

See all of theFuturismpredictions and make your own predictionshere.

More:
When Will We Have a Cure for All Forms of Cancer? – Futurism

Posted in Cancer Cures | Comments Off on When Will We Have a Cure for All Forms of Cancer? – Futurism

Death rates far higher for ‘alternative’ cancer cures: Study – Zee News

Posted: at 2:43 pm

Paris: People who choose alternative cures for common cancers are up to five times more likely to die compared to those opting for standard treatments, the lead scientist of a new study said today.

The risk of death five years after diagnosis “was highest for breast and colon cancer,” said lead author Skyler Johnson from the Yale School of Medicine in New Haven, Connecticut — 5.6 and 4.6 times greater respectively.

Lung cancer patients who spurned surgery, radiation or chemotherapy in favour of herbs and vitamin, homoeopathy, special diets or other unorthodox therapies were more than twice as likely to die over the same period, he reported last week in the Journal of the National Cancer Institute.

Five-year survival rates for prostate cancer remained high around 90 percent for both conventional and alternative treatments, but this was not necessarily evidence that the alternative therapies were as effective.

“Prostate cancer usually grows very slowly in the early stages so few people die,” Johnson told AFP by email.

Faced with poor prognoses or painful courses of chemotherapy, which can cause severe nausea and weakness, many cancer patients place their faith in a wide range of treatments dismissed by most medical doctors as useless at best.

These include probiotics, vitamins and minerals; traditional Indian and Chinese methods such as Ayurvedic medicine and acupuncture; homoeopathy and naturopathy; chiropractic or osteopathic manipulation; as well as yoga, Tai Qi and Qi Gong, all of which involve breath control.

Mind-over-matter approaches also include prayer, meditation, and guided imagery, in which one visualises one’s cancer in order to overcome it.

Researchers led by Johnson identified 281 people in the United States with the four most common types of cancer breast, prostate, lung and colon who turned towards one or more of these unproven treatments when diagnosed.

The team compared their health outcomes with those of 560 other cancer patients of comparable age, also taking into account race and different health factors.

On average, the first group were 2.5 times more likely to die within five years of diagnosis.

“For several reasons, I believe this may be an underestimate,” Johnson told AFP.

To begin with, the data only covered only initial treatment, which means that some of the patients who first sought out alternative cures may have switched to standard treatments as their disease progressed, thus prolonging their lives.

It is also likely, he added, that the non-conventional medicine cohort was heathier, younger and had higher income and education attributes that translate into better survival rates.

“We don’t know the exact number of people that make the decision to pursue alternative medicine instead of conventional cancer treatment,” Johnson said.

Patients are reluctant to confide in doctors who are likely to frown upon their choices, he added.

But, he noted, all the miracle cancer cures on offer probably add up to a multi-billion dollar business.

Read this article:
Death rates far higher for ‘alternative’ cancer cures: Study – Zee News

Posted in Cancer Cures | Comments Off on Death rates far higher for ‘alternative’ cancer cures: Study – Zee News

ZIOPHARM Oncology Inc (ZIOP) Share Performance Recap – FLBC News

Posted: at 2:43 pm

ZIOPHARM Oncology Inc (ZIOP) shares are showing positive momentum over the past week as the stock has clocked in with gains of -9.44%. In taking a look at recent performance, we can see that shares have moved -18.20% over the past 4-weeks, -27.26% over the past half year and -16.13% over the past full year.

Currently, ZIOPHARM Oncology Inc (ZIOP) has a 14-day Commodity Channel Index (CCI) of -181.19. The CCI technical indicator can be employed to help figure out if a stock is overbought or oversold. CCI may also be used to aid in the discovery of divergences that could possibly signal reversal moves. A CCI closer to +100 may provide an overbought signal, and a CCI near -100 may offer an oversold signal.

Tracking other technical indicators, the 14-day RSI is presently standing at 29.30, the 7-day sits at 18.24, and the 3-day is resting at 3.98 for ZIOPHARM Oncology Inc (ZIOP). The Relative Strength Index (RSI) is a highly popular technical indicator. The RSI is computed base on the speed and direction of a stocks price movement. The RSI is considered to be an internal strength indicator, not to be confused with relative strength which is compared to other stocks and indices. The RSI value will always move between 0 and 100. One of the most popular time frames using RSI is the 14-day.

Moving averages have the ability to be used as a powerful indicator for technical stock analysis. Following multiple time frames using moving averages can help investors figure out where the stock has been and help determine where it may be possibly going. The simple moving average is a mathematical calculation that takes the average price (mean) for a given amount of time. Currently, the 7-day moving average is sitting at 5.35.

Lets take a further look at the Average Directional Index or ADX. The ADX measures the strength or weakness of a particular trend. Investors and traders may be looking to figure out if a stock is trending before employing a specific trading strategy. The ADX is typically used along with the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI) which point to the direction of the trend. The 14-day ADX for ZIOPHARM Oncology Inc (ZIOP) is currently at 20.64. In general, and ADX value from 0-25 would represent an absent or weak trend. A value of 25-50 would support a strong trend. A value of 50-75 would signify a very strong trend, and a value of 75-100 would point to an extremely strong trend.

Read the original:
ZIOPHARM Oncology Inc (ZIOP) Share Performance Recap – FLBC News

Posted in Oncology | Comments Off on ZIOPHARM Oncology Inc (ZIOP) Share Performance Recap – FLBC News

Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop … – Markets Insider

Posted: at 2:43 pm

HACKENSACK, N.J., Aug. 18, 2017 /PRNewswire/ –Champions Oncology, Inc. (NASDAQ: CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced a collaboration with The Addario Lung Cancer Medical Institute “ALCMI” to develop a novel cohort of PDX models in patients with ROS1 gene rearrangement. These models will further expand Champions’ TumorGraft bank offerings in non-small cell lung cancer for translational oncology research for academic and industry customers. Champions’ global infrastructure will be leveraged to support this multi-year program.

As a patient-driven initiative, ALCMI is leading an international study, with Champions Oncology contributing its extensive experience and global infrastructure, to support the establishment of patient derived xenograft models from patients with a ROS1 fusion. The unique cohort of PDX models can be used as a resource for clinical and translational research and support development of new therapies in patients with ROS1 positive cancer. The models established will have complete clinical and molecular annotation.

“Champions Oncology is pleased to partner with ALCMI for this patient-driven initiative to establish a unique cohort of models in ROS1 positive cancers,” saidAngela M. Davies, MD, Chief Medical Officer, Champions Oncology Inc.

“Champions and ALCMI are combining their respective infrastructure, expertise and scientific commitment to build PDX models in this rare subtype of cancer and make those models available to academic and industry researchers,” Dr. Davies said. “This PDX resource will facilitate development of new therapies and understanding mechanisms of resistance in ROS1 cancers.”

“We are pleasedto partner with Champions Oncology, and the ROS1 patient community, to help advance our shared goal of new and more effective therapies for affected lung cancer patients everywhere, via the creation and distribution of these much-needed research and development models,” saidSteven Young, ALCMI President & COO.

About ALCMI

The Addario Lung Cancer Medical Institute (ALCMI, voiced as “Alchemy”), founded in 2008 as a 501(c)(3) non-profit organization by lung cancer survivor Bonnie J. Addario, is a patient-centric, international research consortium driving research otherwise not possible. Working in tandem with its “partner” foundation the Bonnie J. Addario Lung Cancer Foundation (ALCF), ALCMI powers collaborative initiatives in genetic (molecular) testing, therapeutic discoveries, targeted treatments and early detection. ALCMI overcomes barriers to collaboration via a world-class team of investigators from 26 member institutions in the USA, UK, and Europe, supported by dedicated, centralized research infrastructures such as standardized biorepositories and data systems. ALCMI directly facilitates research by combining scientific expertise found at leading academic institutions with patient access through its network of community cancer centers accelerating novel research advancements to lung cancer patients. By providing access to critical masses of patient stakeholders, academic, community and industry researchers, ALCMI and ALCF are making progress towards their shared goal of transforming lung cancer into a chronically managed disease by 2023.

About Champions Oncology

Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune-deficient mice to create TumorGrafts that preserve the biological characteristics of the original human tumor to determine the efficacy of a treatment regimen. The company uses this technology in conjunction with related services to offer solutions for two customer groups: Personalized Oncology Solutions, in which results help guide the development of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs. For more information, please visitwww.championsoncology.com.

View original content:http://www.prnewswire.com/news-releases/champions-oncology-announces-research-collaboration-with-the-addario-lung-cancer-medical-institute-to-develop-unique-cohort-of-patient-derived-xenograft-pdx-models-300506481.html

SOURCE Champions Oncology, Inc.

Excerpt from:
Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop … – Markets Insider

Posted in Oncology | Comments Off on Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop … – Markets Insider

Teton Valley Hospital to provide oncology services – KIFI – LocalNews8.com

Posted: at 2:43 pm

DRIGGS, Idaho (KIFI/KIDK) – Teton Valley Health Care has announced it will partner with Utah-based Intermountain Healthcare to provide select oncology care at the Driggs hospital. Teton Valley Hospital will provide expanded services including chemo-infusion therapies, wound care, and personalized treatment programs.

Teton Valley Health Care CEO Keith Gnagey said Intermountain Health Care would provide a variety of cancer screening and treatment services.

“They have an established program in providing tele-health oncology services and TVHC will partner with their multidisciplinary teams to offer cancer care in Teton Valley,” said Gnagey. “Our patients will have real-time visits, care planning, and follow-up exams with some of the best oncologists in the nation, all without having to travel outside the valley.”

Dr. Derrick Haslem of St. George, Utah is based at the Southwest Regional Cancer Clinic at Intermountain’s Dixie Regional Medical Center and is director of Medical Oncology.

“Our Oncology TeleHealth program with Teton Valley Hospital will help patients and their families in many ways,” said Haslem. “For patients, there will be a significant reduction in travel time and expenses, on top of building strong relationships between our two clinical teams. We’ve visited Teton Valley Hospital and have met with their care teams. We’re impressed by what we’ve learned, and we look forward to becoming a part of the community,” he said.

The hospital is working with Intermountain Health Care to complete training and equipment requirements.

Teton Valley Health Care anticipates opening the new oncology services for patients during the first week of October.

Link:
Teton Valley Hospital to provide oncology services – KIFI – LocalNews8.com

Posted in Oncology | Comments Off on Teton Valley Hospital to provide oncology services – KIFI – LocalNews8.com

Page 3«..2345..1020..»